RE:RE:PUMP and DUMP ?My best explanation of this admittedly strange stock price behavior is the company did almost no investor relations for a very long time and investor interest in the stock evaporated as a result. When the good news was published this summer it was only a few people here who were paying attention and we were already fully loaded with the stock. The biotech sector was just starting to recover from a nasty sell-off at that tie as well. Basically, the news was very good but since management allowed investor interest in the stock to "bleed out" in the previous months, nobody cared. Now, itis my guess that management has made it clear to the brokers that they will need to raise money if they have good cancer news and the brokers sensing the opportunity to make a buck on a share offering, are suddenly interested in the stock again. This is evident from the previously extremely apathetic Canaccord analyst suddenly paying attention again and cleaning up his model for no apparent reason and also giving THTX a prime spot at their conference. This week, the Research Capital analyst has set up meetings for THTX management with some of their institutional clients in Montreal and Toronto. So, it appears that there was just enough life left in the stock for it to be resuscitated before it died completely due to prospect of a share offering and the big fees associated with that for the brokers.
That is my best explanation.
The buying today and on Friday, as well as maybe before that too, is likely related to Research Capital's renewed efforts to stir up some interest in the stock. Hopefully, there is an institution willing to take a risk on such a low priced, low market cap, low trading volume stock and they will push the stock up further. Better yet, hopefully, THTX will produce a protocol extension in some form of cancer they are seeing good early results on and that will lead to investors really starting to see what we have been talking about here for a long time, thereby chasing the stock higher still prior to any offering beng implemented to fund a potential pahse II (and maybe more than one of them).
qwerty22 wrote: Back in July they report their Partial Response patient, other efficacy signs in 1a, the program moving on to phase 1b, an incomplete but benign looking safety profile at the the RP2D. They also reported sorting out some near/mid term financing issues. All that looked like significant milestones. It generated less volume in the US than today and less SP reaction.( the volume today isn't massive or massively greater than back in July)
What's going on?
Is the world upside down? Am I upside down? Have they actually primed the market to react to good news? Has ESMO got people googling cancer atm?
It doesn't quite make sense to me.
FredTheVoice wrote: Muslix, it seems that your theory was false.......
Lets see what tomorrow brings.
Just read that a poster sold at these ridiculous price.......WOW
FTV